# Effects of Ritonavir, Lopinavir, and Alcohol on ABC Transporters and Secretion of Bile Acid and Bilirubin in Senescent Hepatocytes

**Authors:** Liting Chen, Eric Duran, Diego Headrick, Cheng Ji

PMC · DOI: 10.3390/ijms27031189 · International Journal of Molecular Sciences · 2026-01-25

## TL;DR

This study shows that aging liver cells secrete bile acids and bilirubin less efficiently when exposed to drugs and alcohol, but this can be improved with specific treatments.

## Contribution

The study reveals how senescence affects drug- and alcohol-induced liver injury through changes in bile transporters and identifies potential treatments.

## Key findings

- Senescent hepatocytes show impaired bile acid and bilirubin secretion when exposed to ritonavir, lopinavir, and alcohol.
- Knockdown of ABCC6 increases intracellular bile acids and alters senescence markers.
- Anti-cholestasis agents like ursodeoxycholic acid and glycyrrhizin improve secretion and reduce cell damage.

## Abstract

Drug- and alcohol-induced liver injury involves impaired bile acids or bilirubin secretion, but it is not known how senescence influences the secretion of hepatocytes exposed to drugs and alcohol. In this study, the toxic effects of ritonavir, lopinavir, and alcohol on hepatocyte transporters and the secretion of bile acids and bilirubin were investigated in hydrogen peroxide-induced senescent HepG2 and doxorubicin-induced senescent primary human hepatocytes. In HepG2, intracellular conjugated bilirubin increased upon senescence and extracellular conjugated bilirubin in culture medium was decreased by ritonavir and lopinavir treatment. In the primary hepatocytes, intracellular bile acids or medium bilirubin were not significantly changed upon senescence. However, intracellular bile acids were increased, and medium conjugated bilirubin were decreased in senescent primary hepatocytes treated with alcohol and the two drugs. Transcriptional expressions of adenosine triphosphate (ATP)-binding cassette (ABC) transporters (ABCB4, ABCC6, ABCB11, and ABCD3) were decreased whereas UDP-glucuronosyltransferase (UGT1A1) was increased by ritonavir and lopinavir in senescent HepG2. In senescent primary hepatocytes, expressions of ABCB11, ABCC1, ABCC2, ABCC3, ABCC4, and ABCC6 were apparently reduced whereas UGT1A1 and the cytochrome P450 enzyme CYP7A1 were markedly increased by alcohol combined with ritonavir and lopinavir. Selective ABCC6 knockdown in the primary hepatocytes altered expressions of two senescence markers, Lamin A/C and cyclin-dependent kinase inhibitor CKI (p21), increased expressions of CYP7A1 and hydroxy methyl glutaryl-CoA reductase (HMGCR), and increased intracellular bile acids. Further, anti-cholestasis agents, ursodeoxycholic acid and glycyrrhizin, significantly ameliorated the impaired secretions of bile acids and bilirubin as well as reducing intracellular lipid accumulation and cell death caused by ritonavir, lopinavir, and alcohol in the primary hepatocytes with ABCC6 knockdown. These results indicate that senescence moderately impairs the ABC transporters of hepatocytes and secretion of bile acids or bilirubin, which become worse in the presence of the drugs and alcohol but could be improved by anti-cholestasis agents.

## Linked entities

- **Genes:** ABCB4 (ATP binding cassette subfamily B member 4) [NCBI Gene 5244], ABCC6 (ATP binding cassette subfamily C member 6) [NCBI Gene 368], ABCB11 (ATP binding cassette subfamily B member 11) [NCBI Gene 8647], ABCD3 (ATP binding cassette subfamily D member 3) [NCBI Gene 5825], UGT1A1 (UDP glucuronosyltransferase family 1 member A1) [NCBI Gene 54658], ABCC1 (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) [NCBI Gene 4363], ABCC2 (ATP binding cassette subfamily C member 2) [NCBI Gene 1244], ABCC3 (ATP binding cassette subfamily C member 3) [NCBI Gene 8714], ABCC4 (ATP binding cassette subfamily C member 4 (PEL blood group)) [NCBI Gene 10257], CYP7A1 (cytochrome P450 family 7 subfamily A member 1) [NCBI Gene 1581], Lmna (lamin A/C) [NCBI Gene 100757316], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156]
- **Chemicals:** ritonavir (PubChem CID 5076), lopinavir (PubChem CID 92727), alcohol (PubChem CID 702), doxorubicin (PubChem CID 31703), ursodeoxycholic acid (PubChem CID 31401), glycyrrhizin (PubChem CID 14982)

## Full-text entities

- **Genes:** ABCC2 (ATP binding cassette subfamily C member 2) [NCBI Gene 1244] {aka ABC30, CMOAT, DJS, MRP2, cMRP}, ABCC4 (ATP binding cassette subfamily C member 4 (PEL blood group)) [NCBI Gene 10257] {aka MOAT-B, MOATB, MRP4}, CHKA (choline kinase alpha) [NCBI Gene 1119] {aka CHK, CK, CKI, EK, NEDMIMS}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, CYP7A1 (cytochrome P450 family 7 subfamily A member 1) [NCBI Gene 1581] {aka CP7A, CYP7, CYPVII}, ABCC6 (ATP binding cassette subfamily C member 6) [NCBI Gene 368] {aka ABC34, ARA, EST349056, GACI2, MLP1, MOAT-E}, ABCD3 (ATP binding cassette subfamily D member 3) [NCBI Gene 5825] {aka ABC43, CBAS5, OPDM5, PMP70, PXMP1, ZWS2}, ABCB11 (ATP binding cassette subfamily B member 11) [NCBI Gene 8647] {aka ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4}, UGT1A1 (UDP glucuronosyltransferase family 1 member A1) [NCBI Gene 54658] {aka BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT 1-1, UGT1}, ABCB4 (ATP binding cassette subfamily B member 4) [NCBI Gene 5244] {aka ABC21, GBD1, ICP3, MDR2, MDR2/3, MDR3}, ABCC3 (ATP binding cassette subfamily C member 3) [NCBI Gene 8714] {aka ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, ABCC1 (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) [NCBI Gene 4363] {aka ABC29, ABCC, DFNA77, GS-X, MRP, MRP1}
- **Diseases:** liver injury (MESH:D017093), cholestasis (MESH:D002779)
- **Chemicals:** Bilirubin (MESH:D001663), hydrogen peroxide (MESH:D006861), Alcohol (MESH:D000438), Ritonavir (MESH:D019438), Bile Acid (MESH:D001647), lipid (MESH:D008055), doxorubicin (MESH:D004317), Lopinavir (MESH:D061466), conjugated bilirubin (-), glycyrrhizin (MESH:D019695), ursodeoxycholic acid (MESH:D014580)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12897732/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12897732/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12897732/full.md

---
Source: https://tomesphere.com/paper/PMC12897732